We next determined patient prognosis for BLCA tumors stratified for the expression of TNFRSF14 and CD160. High expression of both TNFRSF14 and CD160 in BLCA tumors was associated with more favorable patient prognosis compared with all the other groups (Figure 5B). Here, TNFRSF14 is linked to bladder transitional cell carcinoma.